OCUL
Price
$12.00
Change
-$0.35 (-2.83%)
Updated
Aug 5 closing price
Capitalization
1.91B
96 days until earnings call
PRAX
Price
$47.79
Change
-$3.30 (-6.46%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
1.01B
92 days until earnings call
Interact to see
Advertisement

OCUL vs PRAX

Header iconOCUL vs PRAX Comparison
Open Charts OCUL vs PRAXBanner chart's image
Ocular Therapeutix
Price$12.00
Change-$0.35 (-2.83%)
Volume$4.33M
Capitalization1.91B
Praxis Precision Medicines
Price$47.79
Change-$3.30 (-6.46%)
Volume$4.23K
Capitalization1.01B
OCUL vs PRAX Comparison Chart in %
Loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCUL vs. PRAX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Hold and PRAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (OCUL: $12.00 vs. PRAX: $47.79)
Brand notoriety: OCUL and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 172% vs. PRAX: 203%
Market capitalization -- OCUL: $1.91B vs. PRAX: $1.01B
OCUL [@Biotechnology] is valued at $1.91B. PRAX’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRAX is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 3 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • OCUL’s TA Score: 3 bullish, 5 bearish.
  • PRAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than OCUL.

Price Growth

OCUL (@Biotechnology) experienced а +2.13% price change this week, while PRAX (@Biotechnology) price change was -14.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.41%. For the same industry, the average monthly price growth was +15.08%, and the average quarterly price growth was +12.00%.

Reported Earning Dates

OCUL is expected to report earnings on Nov 10, 2025.

PRAX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.91B) has a higher market cap than PRAX($1.01B). OCUL YTD gains are higher at: 40.515 vs. PRAX (-33.615). OCUL has higher annual earnings (EBITDA): -176.35M vs. PRAX (-232.71M). OCUL has more cash in the bank: 350M vs. PRAX (328M). PRAX has less debt than OCUL: PRAX (1.07M) vs OCUL (76.2M). OCUL has higher revenues than PRAX: OCUL (59.6M) vs PRAX (8.12M).
OCULPRAXOCUL / PRAX
Capitalization1.91B1.01B190%
EBITDA-176.35M-232.71M76%
Gain YTD40.515-33.615-121%
P/E RatioN/AN/A-
Revenue59.6M8.12M734%
Total Cash350M328M107%
Total Debt76.2M1.07M7,148%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCULPRAX
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PENNX9.120.16
+1.79%
Royce Small-Cap Fund Invmt
PLJMX57.19N/A
N/A
Putnam Research R6
ACMVX15.99N/A
N/A
American Century Mid Cap Value Inv
SRECX13.03N/A
N/A
PGIM Select Real Estate C
JINTX33.06N/A
N/A
Johnson International

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-5.55%
CDXS - PRAX
50%
Loosely correlated
+5.58%
DNLI - PRAX
46%
Loosely correlated
+7.44%
MNMD - PRAX
46%
Loosely correlated
+10.90%
ABCL - PRAX
41%
Loosely correlated
+2.36%
OCUL - PRAX
40%
Loosely correlated
+3.61%
More